IBUPROFEN TABLETS, COATED

IBUPROFEN TABLETS, COATED was reported 42678 times

These side effects are most commonly reported by patients taking IBUPROFEN TABLETS, COATED:

# Side effect Count
0 DRUG INEFFECTIVE 6860
1 NAUSEA 2746
2 FATIGUE 2728
3 HEADACHE 2606
4 PAIN 2497
5 DIARRHOEA 1808
6 PRODUCT USE IN UNAPPROVED INDICATION 1802
7 DIZZINESS 1761
8 ARTHRALGIA 1684
9 OFF LABEL USE 1522
10 DYSPNOEA 1448
11 VOMITING 1398
12 MALAISE 1362
13 ABDOMINAL DISCOMFORT 1307
14 RASH 1255
15 PAIN IN EXTREMITY 1206
16 PRURITUS 1188
17 ABDOMINAL PAIN UPPER 1178
18 INSOMNIA 1105
19 CONDITION AGGRAVATED 1098
20 ASTHENIA 1080
21 ANXIETY 1068
22 FEELING ABNORMAL 1045
23 BACK PAIN 1016
24 DRUG HYPERSENSITIVITY 996
25 PYREXIA 973
26 COUGH 964
27 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 939
28 FALL 870
29 DEPRESSION 852
30 HYPERSENSITIVITY 848
31 NASOPHARYNGITIS 816
32 WEIGHT DECREASED 813
33 CONSTIPATION 794
34 SOMNOLENCE 767
35 GAIT DISTURBANCE 759
36 DYSPEPSIA 755
37 ABDOMINAL PAIN 744
38 URTICARIA 740
39 MUSCLE SPASMS 735
40 CHEST PAIN 733
41 WEIGHT INCREASED 715
42 HYPERTENSION 711
43 PRODUCT USE ISSUE 698
44 HYPOAESTHESIA 696
45 BLOOD PRESSURE INCREASED 685
46 PERIPHERAL SWELLING 684
47 JOINT SWELLING 648
48 PARAESTHESIA 641
49 HYPERHIDROSIS 639
50 SINUSITIS 625
51 INTENTIONAL PRODUCT MISUSE 623
52 DECREASED APPETITE 620
53 MYALGIA 607
54 PNEUMONIA 596
55 COVID-19 579
56 RHEUMATOID ARTHRITIS 565
57 MIGRAINE 549
58 ALOPECIA 538
59 INCORRECT DOSE ADMINISTERED 534
60 ERYTHEMA 533
61 DRUG EFFECT INCOMPLETE 527
62 MUSCULOSKELETAL STIFFNESS 525
63 OVERDOSE 523
64 PRODUCT DOSE OMISSION ISSUE 512
65 OROPHARYNGEAL PAIN 500
66 DYSPHAGIA 496
67 INJECTION SITE PAIN 495
68 URINARY TRACT INFECTION 492
69 TREMOR 473
70 DRUG INTOLERANCE 460
71 DYSGEUSIA 446
72 INTENTIONAL PRODUCT USE ISSUE 440
73 DEATH 437
74 SWELLING 433
75 THROAT IRRITATION 432
76 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 431
77 ARTHRITIS 420
78 MEMORY IMPAIRMENT 418
79 VISION BLURRED 413
80 HEART RATE INCREASED 409
81 MUSCULAR WEAKNESS 400
82 CONTUSION 398
83 CHILLS 396
84 CONFUSIONAL STATE 393
85 FLUSHING 389
86 PALPITATIONS 388
87 ANAEMIA 386
88 INJURY 384
89 INFECTION 382
90 GASTROINTESTINAL DISORDER 380
91 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 379
92 INFLUENZA 378
93 INFLUENZA LIKE ILLNESS 372
94 DRY MOUTH 371
95 HYPOTENSION 365
96 OEDEMA PERIPHERAL 363
97 ABDOMINAL DISTENSION 361
98 THERAPEUTIC RESPONSE UNEXPECTED 360
99 POOR QUALITY DRUG ADMINISTERED 358
100 GASTROOESOPHAGEAL REFLUX DISEASE 353
101 SWELLING FACE 352
102 ASTHMA 344
103 CHEST DISCOMFORT 344
104 BALANCE DISORDER 340
105 NEPHROLITHIASIS 339
106 MUSCULOSKELETAL PAIN 331
107 SLEEP DISORDER 330
108 DISCOMFORT 329
109 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327
110 MOBILITY DECREASED 325
111 DEHYDRATION 324
112 PRODUCT QUALITY ISSUE 322
113 BURNING SENSATION 320
114 RENAL FAILURE 320
115 CEREBROVASCULAR ACCIDENT 319
116 MYOCARDIAL INFARCTION 318
117 NIGHTMARE 317
118 HOT FLUSH 313
119 GASTRIC DISORDER 311
120 ARTHROPATHY 307
121 STRESS 305
122 NECK PAIN 304
123 GENERAL PHYSICAL HEALTH DETERIORATION 303
124 ILLNESS 302
125 WHITE BLOOD CELL COUNT DECREASED 298
126 DRY SKIN 295
127 INFLAMMATION 295
128 PSORIASIS 294
129 PULMONARY EMBOLISM 294
130 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 293
131 INFUSION RELATED REACTION 289
132 VISUAL IMPAIRMENT 287
133 EMOTIONAL DISTRESS 282
134 BRONCHITIS 278
135 SEDATION 275
136 STOMATITIS 275
137 FEELING HOT 273
138 PRODUCT PHYSICAL ISSUE 270
139 BLOOD CHOLESTEROL INCREASED 267
140 ACUTE KIDNEY INJURY 265
141 RHINORRHOEA 264
142 LOSS OF CONSCIOUSNESS 258
143 DEEP VEIN THROMBOSIS 253
144 HAEMOGLOBIN DECREASED 253
145 DRUG DOSE OMISSION 252
146 NEUROPATHY PERIPHERAL 252
147 INJECTION SITE ERYTHEMA 249
148 HEPATIC ENZYME INCREASED 243
149 BLOOD GLUCOSE INCREASED 241
150 EPISTAXIS 239
151 FLATULENCE 236
152 PRODUCT TASTE ABNORMAL 236
153 RENAL DISORDER 236
154 BLISTER 235
155 OSTEOARTHRITIS 233
156 CHRONIC KIDNEY DISEASE 231
157 GASTROINTESTINAL HAEMORRHAGE 230
158 HAEMORRHAGE 228
159 MULTIPLE SCLEROSIS RELAPSE 228
160 PLATELET COUNT DECREASED 225
161 EYE PAIN 223
162 EYE SWELLING 223
163 DRUG EFFECT DECREASED 221
164 GLOSSODYNIA 221
165 LIVER DISORDER 221
166 SUICIDAL IDEATION 220
167 AMNESIA 219
168 DRUG INTERACTION 219
169 WHEEZING 216
170 BONE PAIN 214
171 NASAL CONGESTION 214
172 TINNITUS 211
173 PSORIATIC ARTHROPATHY 209
174 EXPIRED PRODUCT ADMINISTERED 208
175 HAEMATOCHEZIA 208
176 NIGHT SWEATS 207
177 LIP SWELLING 206
178 SYNCOPE 203
179 ILL-DEFINED DISORDER 201
180 IRRITABLE BOWEL SYNDROME 201
181 VERTIGO 200
182 ORAL DISCOMFORT 199
183 MATERNAL EXPOSURE DURING PREGNANCY 197
184 LOWER RESPIRATORY TRACT INFECTION 196
185 UPPER RESPIRATORY TRACT INFECTION 196
186 NERVOUSNESS 195
187 RECTAL HAEMORRHAGE 194
188 LUNG DISORDER 193
189 UNEVALUABLE EVENT 191
190 SKIN EXFOLIATION 190
191 GAIT INABILITY 189
192 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 189
193 EAR INFECTION 187
194 ROAD TRAFFIC ACCIDENT 185
195 THROMBOSIS 184
196 COLITIS ULCERATIVE 181
197 CARDIAC DISORDER 178
198 DRY EYE 177
199 IMPAIRED HEALING 177
200 PRODUCTIVE COUGH 177
201 DISEASE RECURRENCE 176
202 GASTRIC ULCER 175
203 CONTRAINDICATED PRODUCT ADMINISTERED 174
204 FOREIGN BODY 172
205 SEIZURE 172
206 TREATMENT FAILURE 172
207 INJECTION SITE BRUISING 168
208 DISEASE PROGRESSION 167
209 CATARACT 166
210 NEUTROPENIA 165
211 THERAPEUTIC PRODUCT EFFECT DECREASED 165
212 ADVERSE DRUG REACTION 164
213 EXTRA DOSE ADMINISTERED 164
214 SCIATICA 163
215 RASH PRURITIC 162
216 ANAPHYLACTIC REACTION 161
217 DYSPHONIA 161
218 HERPES ZOSTER 161
219 MULTIPLE SCLEROSIS 161
220 CELLULITIS 160
221 RENAL FAILURE ACUTE 160
222 TACHYCARDIA 158
223 ACNE 157
224 PANIC ATTACK 155
225 CROHN^S DISEASE 154
226 OSTEOPOROSIS 153
227 DEPRESSED MOOD 150
228 OEDEMA 150
229 ATRIAL FIBRILLATION 149
230 DYSURIA 149
231 INTENTIONAL OVERDOSE 149
232 DRUG EFFECT LESS THAN EXPECTED 148
233 POLLAKIURIA 148
234 SKIN DISCOLOURATION 148
235 IRRITABILITY 147
236 THROMBOCYTOPENIA 147
237 CHOKING 146
238 DISTURBANCE IN ATTENTION 146
239 HYPOAESTHESIA ORAL 146
240 THROAT TIGHTNESS 146
241 ALANINE AMINOTRANSFERASE INCREASED 145
242 FIBROMYALGIA 145
243 JOINT RANGE OF MOTION DECREASED 145
244 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 144
245 BLOOD PRESSURE DECREASED 143
246 DRUG EFFECT DELAYED 143
247 PRODUCT SUBSTITUTION ISSUE 142
248 SYNOVITIS 142
249 INJECTION SITE REACTION 141
250 OXYGEN SATURATION DECREASED 141
251 PRODUCT USE COMPLAINT 141
252 HALLUCINATION 140
253 JOINT STIFFNESS 140
254 HEART RATE DECREASED 139
255 SPEECH DISORDER 139
256 INJECTION SITE SWELLING 138
257 RASH ERYTHEMATOUS 138
258 WHITE BLOOD CELL COUNT INCREASED 138
259 GASTRITIS 137
260 AGITATION 135
261 CHOLELITHIASIS 134
262 LETHARGY 133
263 LIMB INJURY 133
264 LYMPHADENOPATHY 133
265 AUTOIMMUNE DISORDER 132
266 BLOOD PRESSURE FLUCTUATION 132
267 DIABETES MELLITUS 132
268 FREQUENT BOWEL MOVEMENTS 131
269 SKIN BURNING SENSATION 130
270 LOWER LIMB FRACTURE 129
271 BURSITIS 128
272 TYPE 2 DIABETES MELLITUS 128
273 INJECTION SITE HAEMORRHAGE 127
274 ADVERSE EVENT 126
275 DRUG DEPENDENCE 126
276 EYE IRRITATION 126
277 INJECTION SITE PRURITUS 126
278 SEPSIS 126
279 OCULAR HYPERAEMIA 124
280 PLEURAL EFFUSION 123
281 VIRAL INFECTION 121
282 SWOLLEN TONGUE 120
283 SYSTEMIC LUPUS ERYTHEMATOSUS 120
284 WOUND 120
285 EYE DISORDER 119
286 EAR PAIN 118
287 LIVER INJURY 118
288 RASH MACULAR 118
289 THERAPY CESSATION 118
290 PANCREATITIS 116
291 SUICIDE ATTEMPT 116
292 CONVULSION 115
293 LIP DRY 115
294 MEDICATION ERROR 113
295 THERAPY NON-RESPONDER 113
296 DYSSTASIA 112
297 COELIAC DISEASE 111
298 FLUID RETENTION 111
299 PRODUCT DOSE OMISSION 111
300 DUODENAL ULCER PERFORATION 110
301 FAECES DISCOLOURED 110
302 LIMB DISCOMFORT 110
303 CORONARY ARTERY DISEASE 109
304 CRYING 109
305 LABORATORY TEST ABNORMAL 109
306 THERAPEUTIC RESPONSE DECREASED 109
307 GASTRIC HAEMORRHAGE 108
308 SURGERY 108
309 ULCER 108
310 MIDDLE INSOMNIA 107
311 MUSCLE INJURY 107
312 POOR QUALITY SLEEP 107
313 SINUS DISORDER 107
314 THERAPY INTERRUPTED 107
315 CYSTITIS 106
316 RENAL IMPAIRMENT 106
317 WRONG TECHNIQUE IN DRUG USAGE PROCESS 106
318 ANKYLOSING SPONDYLITIS 105
319 COGNITIVE DISORDER 105
320 DYSPNOEA EXERTIONAL 105
321 ORAL PAIN 105
322 C-REACTIVE PROTEIN INCREASED 104
323 FUNGAL INFECTION 104
324 SKIN DISORDER 104
325 ASPARTATE AMINOTRANSFERASE INCREASED 103
326 BLOOD PRESSURE SYSTOLIC INCREASED 103
327 EXOSTOSIS 103
328 GRIP STRENGTH DECREASED 103
329 HAEMATEMESIS 103
330 HOSPITALISATION 103
331 MOVEMENT DISORDER 103
332 UNDERDOSE 103
333 ECZEMA 102
334 FEELING COLD 102
335 INTERVERTEBRAL DISC PROTRUSION 102
336 ACCIDENTAL EXPOSURE TO PRODUCT 101
337 BLOOD CREATININE INCREASED 101
338 HYPOKALAEMIA 101
339 SNEEZING 101
340 TRANSIENT ISCHAEMIC ATTACK 101
341 C-REACTIVE PROTEIN ABNORMAL 100
342 NEURALGIA 98
343 FOLLICULITIS 97
344 HAND DEFORMITY 97
345 HELICOBACTER INFECTION 97
346 PAIN IN JAW 97
347 PRE-EXISTING CONDITION IMPROVED 97
348 ANHEDONIA 96
349 DELIRIUM 96
350 HYPERSOMNIA 96
351 PRODUCT COMPLAINT 96
352 RETCHING 96
353 NO ADVERSE EVENT 95
354 OBESITY 95
355 POOR QUALITY PRODUCT ADMINISTERED 94
356 RASH GENERALISED 94
357 WITHDRAWAL SYNDROME 94
358 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 93
359 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 93
360 LOCALISED INFECTION 93
361 MALIGNANT NEOPLASM PROGRESSION 93
362 SEASONAL ALLERGY 93
363 THERAPEUTIC RESPONSE SHORTENED 93
364 FEAR 92
365 HYPOACUSIS 92
366 LACRIMATION INCREASED 92
367 URINARY RETENTION 92
368 CARDIAC FAILURE CONGESTIVE 91
369 FACET JOINT SYNDROME 91
370 FEELING JITTERY 91
371 PRESCRIBED OVERDOSE 91
372 MOOD SWINGS 89
373 PRODUCT ODOUR ABNORMAL 89
374 RASH PAPULAR 89
375 RIB FRACTURE 89
376 CHOLECYSTITIS CHRONIC 88
377 FOOT DEFORMITY 88
378 TOOTH DISORDER 88
379 ACCIDENTAL OVERDOSE 87
380 MUSCULOSKELETAL DISCOMFORT 87
381 MUSCULOSKELETAL DISORDER 87
382 HYPONATRAEMIA 86
383 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86
384 DYSARTHRIA 85
385 EYE PRURITUS 85
386 HEAD INJURY 85
387 JOINT INJURY 85
388 RHEUMATIC FEVER 85
389 WOUND INFECTION 85
390 DRUG WITHDRAWAL SYNDROME 84
391 HYPERCHOLESTEROLAEMIA 84
392 RED BLOOD CELL COUNT DECREASED 84
393 RESPIRATORY DISORDER 84
394 TOOTHACHE 84
395 TOXICITY TO VARIOUS AGENTS 84
396 URINARY INCONTINENCE 84
397 BLINDNESS 83
398 PERICARDITIS 83
399 PHARYNGEAL OEDEMA 83
400 PRODUCT COATING ISSUE 83
401 PRODUCT SIZE ISSUE 83
402 ANGER 82
403 PEMPHIGUS 82
404 RHEUMATOID FACTOR POSITIVE 82
405 SKIN IRRITATION 82
406 BONE DISORDER 81
407 CHROMATURIA 81
408 DEEP VEIN THROMBOSIS POSTOPERATIVE 81
409 EXPOSURE DURING PREGNANCY 81
410 ABNORMAL DREAMS 80
411 ANGINA PECTORIS 80
412 BLOOD URINE PRESENT 80
413 HEPATITIS 80
414 IMPAIRED WORK ABILITY 80
415 INTERVERTEBRAL DISC DEGENERATION 80
416 LARYNGITIS 80
417 MENTAL DISORDER 80
418 MUSCULOSKELETAL CHEST PAIN 80
419 PRURITUS GENERALISED 80
420 SCAR 80
421 HEAD DISCOMFORT 79
422 ORAL HERPES 79
423 SKIN PAPILLOMA 79
424 BODY HEIGHT DECREASED 78
425 DISORIENTATION 78
426 GALLBLADDER DISORDER 78
427 MOUTH ULCERATION 78
428 RESPIRATORY FAILURE 78
429 BLOOD PRESSURE ABNORMAL 77
430 DIPLOPIA 77
431 HYPOTHYROIDISM 77
432 LIVER FUNCTION TEST INCREASED 77
433 PERIPHERAL VENOUS DISEASE 77
434 RESTLESS LEGS SYNDROME 77
435 WEIGHT FLUCTUATION 77
436 HEART RATE IRREGULAR 76
437 PHOTOPHOBIA 76
438 RENAL INJURY 76
439 STAPHYLOCOCCAL INFECTION 76
440 VAGINAL HAEMORRHAGE 76
441 ACTIVITIES OF DAILY LIVING IMPAIRED 75
442 BREAST CANCER STAGE III 75
443 REACTION TO DRUG EXCIPIENTS 75
444 BODY TEMPERATURE DECREASED 74
445 DEAFNESS 74
446 TENDONITIS 74
447 ANGIOEDEMA 73
448 APHASIA 73
449 BLOOD POTASSIUM DECREASED 73
450 INJECTION SITE RASH 73
451 MUSCLE TIGHTNESS 73
452 TOOTH INFECTION 73
453 AGEUSIA 72
454 DEVICE ISSUE 72
455 DIVERTICULITIS 72
456 DYSKINESIA 72
457 FOOT FRACTURE 72
458 RESPIRATORY TRACT INFECTION 72
459 EMOTIONAL DISORDER 71
460 FEBRILE NEUTROPENIA 71
461 HEPATIC CIRRHOSIS 71
462 SLEEP APNOEA SYNDROME 71
463 TREATMENT NONCOMPLIANCE 71
464 ABDOMINAL PAIN LOWER 70
465 ACUTE MYOCARDIAL INFARCTION 70
466 ANAPHYLACTIC SHOCK 70
467 BLOOD PRESSURE DIASTOLIC ABNORMAL 70
468 CONJUNCTIVITIS 70
469 INJECTION SITE MASS 70
470 LOCAL SWELLING 70
471 PHOTOSENSITIVITY REACTION 70
472 PRODUCT COLOUR ISSUE 70
473 PRODUCT LABEL ISSUE 70
474 ABASIA 69
475 BACK DISORDER 69
476 HIP FRACTURE 69
477 PRESYNCOPE 69
478 PROCEDURAL PAIN 69
479 ULCER HAEMORRHAGE 69
480 BLOOD PRESSURE SYSTOLIC ABNORMAL 68
481 COLITIS 68
482 DISABILITY 68
483 GASTROENTERITIS VIRAL 68
484 HAEMOPTYSIS 68
485 HAEMORRHOIDS 68
486 STEVENS-JOHNSON SYNDROME 68
487 CARPAL TUNNEL SYNDROME 67
488 EATING DISORDER 67
489 INTESTINAL OBSTRUCTION 67
490 MELAENA 67
491 NEOPLASM PROGRESSION 67
492 PARAESTHESIA ORAL 67
493 RESTLESSNESS 67
494 SWOLLEN JOINT COUNT INCREASED 67
495 CONGENITAL ANOMALY 66
496 HYPERLIPIDAEMIA 66
497 MOOD ALTERED 66
498 MUSCLE SPASTICITY 66
499 PRODUCT DOSE OMISSION IN ERROR 66
500 SINUS CONGESTION 66
501 BLOOD PRESSURE DIASTOLIC DECREASED 65
502 DYSMENORRHOEA 65
503 HIATUS HERNIA 65
504 HYPERGLYCAEMIA 65
505 MUSCLE TWITCHING 65
506 NERVE COMPRESSION 65
507 RED BLOOD CELL SEDIMENTATION RATE INCREASED 65
508 SKIN FISSURES 65
509 TASTE DISORDER 65
510 THINKING ABNORMAL 65
511 UPPER GASTROINTESTINAL HAEMORRHAGE 65
512 INTENTIONAL DOSE OMISSION 64
513 KNEE ARTHROPLASTY 64
514 TOXIC EPIDERMAL NECROLYSIS 64
515 ABNORMAL BEHAVIOUR 63
516 HIP ARTHROPLASTY 63
517 KIDNEY INFECTION 63
518 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 62
519 ANKLE FRACTURE 62
520 BREAST CANCER 62
521 DERMATITIS ATOPIC 62
522 JOINT DISLOCATION 62
523 LEUKOPENIA 62
524 PULMONARY OEDEMA 62
525 SKIN LESION 62
526 HAEMATOCRIT DECREASED 61
527 HYPOXIA 61
528 PRODUCT DIFFICULT TO SWALLOW 61
529 DISLOCATION OF VERTEBRA 60
530 GASTRIC ULCER HAEMORRHAGE 60
531 NEOPLASM MALIGNANT 60
532 PHARYNGITIS STREPTOCOCCAL 60
533 RESPIRATORY TRACT CONGESTION 60
534 ROTATOR CUFF SYNDROME 60
535 BONE EROSION 59
536 HAEMATURIA 59
537 INJECTION SITE URTICARIA 59
538 LIVER FUNCTION TEST ABNORMAL 59
539 PELVIC PAIN 59
540 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 58
541 BLOOD ALKALINE PHOSPHATASE INCREASED 58
542 MUSCLE STRAIN 58
543 AGGRESSION 57
544 FOETAL EXPOSURE DURING PREGNANCY 57
545 INFUSION SITE PAIN 57
546 PRODUCT STORAGE ERROR 57
547 THERAPEUTIC PRODUCT EFFECT VARIABLE 57
548 FEEDING DISORDER 56
549 FOREIGN BODY IN THROAT 56
550 LYMPHOCYTE COUNT DECREASED 56
551 TENDERNESS 56
552 TUBULOINTERSTITIAL NEPHRITIS 56
553 ABSCESS 55
554 BLOOD PRESSURE DIASTOLIC INCREASED 55
555 DRUG ADMINISTRATION ERROR 55
556 INCORRECT DRUG ADMINISTRATION DURATION 55
557 MENORRHAGIA 55
558 APHONIA 54
559 BLOOD BILIRUBIN INCREASED 54
560 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54
561 FOREIGN BODY IN RESPIRATORY TRACT 54
562 GINGIVAL BLEEDING 54
563 HERNIA 54
564 HYPOPHAGIA 54
565 OSTEOPENIA 54
566 PNEUMONITIS 54
567 PRODUCT FORMULATION ISSUE 54
568 PULMONARY FIBROSIS 54
569 TENDON DISORDER 54
570 BACK INJURY 53
571 BODY TEMPERATURE INCREASED 53
572 BRADYCARDIA 53
573 DRUG-INDUCED LIVER INJURY 53
574 HEMIPARESIS 53
575 HEPATIC FAILURE 53
576 PALLOR 53
577 RETINITIS 53
578 SPINAL OSTEOARTHRITIS 53
579 THERAPEUTIC PRODUCT EFFECT DELAYED 53
580 COLD SWEAT 52
581 EYELID OEDEMA 52
582 GOUT 52
583 HEPATIC STEATOSIS 52
584 INITIAL INSOMNIA 52
585 LIGAMENT SPRAIN 52
586 LUPUS-LIKE SYNDROME 52
587 MENTAL IMPAIRMENT 52
588 MICTURITION URGENCY 52
589 NEUTROPHIL COUNT DECREASED 52
590 RENAL PAIN 52
591 SENSORY DISTURBANCE 52
592 SKIN ULCER 52
593 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 52
594 SPINAL PAIN 52
595 IMPAIRED DRIVING ABILITY 51
596 MULTIPLE ALLERGIES 51
597 PAIN OF SKIN 51
598 SARS-COV-2 TEST POSITIVE 51
599 SENSATION OF FOREIGN BODY 51
600 ARRHYTHMIA 50
601 BRAIN FOG 50
602 ERUCTATION 50
603 INSURANCE ISSUE 50
604 OSTEOMYELITIS 50
605 THIRST 50
606 CARDIAC ARREST 49
607 EPIGASTRIC DISCOMFORT 49
608 MENTAL STATUS CHANGES 49
609 SEPTIC SHOCK 49
610 BASAL CELL CARCINOMA 48
611 COMA 48
612 DIVERTICULUM 48
613 DRUG ABUSE 48
614 PREGNANCY 48
615 RESPIRATORY DISTRESS 48
616 VITAMIN D DECREASED 48
617 BLINDNESS UNILATERAL 47
618 CENTRAL NERVOUS SYSTEM LESION 47
619 DERMATITIS CONTACT 47
620 END STAGE RENAL DISEASE 47
621 ERECTILE DYSFUNCTION 47
622 HAIR TEXTURE ABNORMAL 47
623 INCREASED APPETITE 47
624 LEUKOCYTOSIS 47
625 OSTEONECROSIS OF JAW 47
626 PHARYNGITIS 47
627 PRESCRIBED UNDERDOSE 47
628 UPPER LIMB FRACTURE 47
629 VISUAL ACUITY REDUCED 47
630 WALKING AID USER 47
631 BLOOD SODIUM DECREASED 46
632 BLOOD TEST ABNORMAL 46
633 DEPRESSED LEVEL OF CONSCIOUSNESS 46
634 DEVICE DISLOCATION 46
635 GASTROINTESTINAL PAIN 46
636 HYPOKINESIA 46
637 MASS 46
638 METRORRHAGIA 46
639 NERVOUS SYSTEM DISORDER 46
640 PANCREATITIS ACUTE 46
641 PRODUCT PACKAGING ISSUE 46
642 SCAB 46
643 SECRETION DISCHARGE 46
644 ASCITES 45
645 CEREBRAL HAEMORRHAGE 45
646 DENTAL CARIES 45
647 FACIAL PAIN 45
648 IRON DEFICIENCY ANAEMIA 45
649 METABOLIC ACIDOSIS 45
650 METASTASES TO BONE 45
651 OESOPHAGEAL PAIN 45
652 PANCYTOPENIA 45
653 PERIPHERAL COLDNESS 45
654 SKIN LACERATION 45
655 SYNOVIAL CYST 45
656 TEMPERATURE INTOLERANCE 45
657 UVEITIS 45
658 X-RAY ABNORMAL 45
659 EXPIRED DRUG ADMINISTERED 44
660 FACE OEDEMA 44
661 INFLAMMATORY BOWEL DISEASE 44
662 PRODUCT ADMINISTRATION ERROR 44
663 BEDRIDDEN 43
664 BLOOD GLUCOSE DECREASED 43
665 CYST 43
666 DEVICE MALFUNCTION 43
667 EYE INFECTION 43
668 GASTROENTERITIS 43
669 GLAUCOMA 43
670 JAUNDICE 43
671 MENSTRUATION IRREGULAR 43
672 MITRAL VALVE INCOMPETENCE 43
673 OVARIAN CYST 43
674 PLASMA CELL MYELOMA 43
675 TOOTH FRACTURE 43
676 VITAMIN D DEFICIENCY 43
677 COORDINATION ABNORMAL 42
678 DERMATITIS 42
679 HAIR COLOUR CHANGES 42
680 IMMUNODEFICIENCY 42
681 INJECTION SITE WARMTH 42
682 TONGUE DISCOMFORT 42
683 BLOOD CALCIUM DECREASED 41
684 BLOOD IRON DECREASED 41
685 BONE DENSITY DECREASED 41
686 EYE HAEMORRHAGE 41
687 FRUSTRATION TOLERANCE DECREASED 41
688 INCREASED TENDENCY TO BRUISE 41
689 TOOTH ABSCESS 41
690 BACTERIAL INFECTION 40
691 BLOOD TRIGLYCERIDES INCREASED 40
692 C-REACTIVE PROTEIN 40
693 CARDIOMEGALY 40
694 DECREASED INTEREST 40
695 DRY THROAT 40
696 DUODENAL ULCER 40
697 EAR DISCOMFORT 40
698 HUNGER 40
699 OESOPHAGITIS 40
700 POST-TRAUMATIC STRESS DISORDER 40
701 THERMAL BURN 40
702 ANOSMIA 39
703 ATELECTASIS 39
704 INCONTINENCE 39
705 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 39
706 SPINAL FRACTURE 39
707 CHOLECYSTITIS 38
708 DEMENTIA 38
709 FEELING OF BODY TEMPERATURE CHANGE 38
710 FULL BLOOD COUNT DECREASED 38
711 GAMMA-GLUTAMYLTRANSFERASE INCREASED 38
712 INTENTIONAL DRUG MISUSE 38
713 PARANOIA 38
714 QUALITY OF LIFE DECREASED 38
715 RENAL TUBULAR NECROSIS 38
716 THROMBOPHLEBITIS SUPERFICIAL 38
717 BREAST PAIN 37
718 CORONARY ARTERY OCCLUSION 37
719 DEFAECATION URGENCY 37
720 IMPAIRED GASTRIC EMPTYING 37
721 INTERNAL HAEMORRHAGE 37
722 ORAL CANDIDIASIS 37
723 OROPHARYNGEAL DISCOMFORT 37
724 PAROSMIA 37
725 PRODUCT AVAILABILITY ISSUE 37
726 SKIN HAEMORRHAGE 37
727 THYROID DISORDER 37
728 UPPER-AIRWAY COUGH SYNDROME 37
729 WRONG DRUG ADMINISTERED 37
730 ABORTION SPONTANEOUS 36
731 ACUTE RESPIRATORY FAILURE 36
732 APHTHOUS ULCER 36
733 ARTHROPOD BITE 36
734 CANDIDA INFECTION 36
735 CORONARY ARTERY STENOSIS 36
736 DRUG SCREEN POSITIVE 36
737 FEELING DRUNK 36
738 MADAROSIS 36
739 PHARMACEUTICAL PRODUCT COMPLAINT 36
740 PSYCHOMOTOR HYPERACTIVITY 36
741 PULMONARY MASS 36
742 RASH MACULO-PAPULAR 36
743 ROSACEA 36
744 BLOOD COUNT ABNORMAL 35
745 CARDIOVASCULAR DISORDER 35
746 CHOLECYSTECTOMY 35
747 CLOSTRIDIUM DIFFICILE INFECTION 35
748 EAR DISORDER 35
749 GINGIVAL PAIN 35
750 HAEMATOMA 35
751 INJECTION SITE INDURATION 35
752 NASAL DISCOMFORT 35
753 POST PROCEDURAL COMPLICATION 35
754 SKIN CANCER 35
755 SLUGGISHNESS 35
756 ANOREXIA 34
757 BOWEL MOVEMENT IRREGULARITY 34
758 CARDIAC MURMUR 34
759 CEREBRAL INFARCTION 34
760 DECREASED ACTIVITY 34
761 EPILEPSY 34
762 IMMUNE SYSTEM DISORDER 34
763 MUSCLE ATROPHY 34
764 NERVE INJURY 34
765 ODYNOPHAGIA 34
766 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34
767 PLATELET COUNT INCREASED 34
768 PULMONARY CONGESTION 34
769 TONGUE DISORDER 34
770 UTERINE LEIOMYOMA 34
771 VITREOUS FLOATERS 34
772 APATHY 33
773 APPLICATION SITE PAIN 33
774 BLOOD DISORDER 33
775 FLANK PAIN 33
776 HALLUCINATION, VISUAL 33
777 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 33
778 INFUSION SITE ERYTHEMA 33
779 LACERATION 33
780 LUNG NEOPLASM MALIGNANT 33
781 LUPUS VULGARIS 33
782 SWOLLEN JOINT COUNT 33
783 TOOTH EXTRACTION 33
784 BLADDER DISORDER 32
785 BLOOD UREA INCREASED 32
786 CARDIAC FAILURE 32
787 CARDIO-RESPIRATORY ARREST 32
788 DRUG TOXICITY 32
789 ECONOMIC PROBLEM 32
790 JOINT EFFUSION 32
791 MUSCLE DISORDER 32
792 OCULAR DISCOMFORT 32
793 ORAL DISORDER 32
794 PANIC REACTION 32
795 PARANASAL SINUS DISCOMFORT 32
796 PNEUMONIA ASPIRATION 32
797 PROSTATE CANCER 32
798 RHABDOMYOLYSIS 32
799 SENSORY LOSS 32
800 SINUS HEADACHE 32
801 TRICUSPID VALVE INCOMPETENCE 32
802 VITAMIN B12 DECREASED 32
803 WRIST FRACTURE 32
804 BILIARY DYSKINESIA 31
805 BLOOD CALCIUM INCREASED 31
806 BRONCHOSPASM 31
807 COMPLETED SUICIDE 31
808 DIZZINESS POSTURAL 31
809 HANGOVER 31
810 HYPOGLYCAEMIA 31
811 IMPAIRED QUALITY OF LIFE 31
812 NAIL DISORDER 31
813 PARALYSIS 31
814 PSYCHOTIC DISORDER 31
815 TENSION HEADACHE 31
816 TOOTH LOSS 31
817 ACCIDENT 30
818 CHEILITIS 30
819 DRUG TOLERANCE 30
820 ENERGY INCREASED 30
821 EYE DISCHARGE 30
822 HYSTERECTOMY 30
823 INCORRECT PRODUCT ADMINISTRATION DURATION 30
824 INCREASED UPPER AIRWAY SECRETION 30
825 LIBIDO DECREASED 30
826 LYMPHOEDEMA 30
827 MOUTH SWELLING 30
828 NASAL DRYNESS 30
829 OSTEONECROSIS 30
830 PRODUCT COMMINGLING 30
831 RHINITIS 30
832 SINUS TACHYCARDIA 30
833 TENDON RUPTURE 30
834 VISUAL DISTURBANCE 30
835 BLOOD CREATINE PHOSPHOKINASE INCREASED 29
836 DIARRHOEA HAEMORRHAGIC 29
837 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29
838 EUPHORIC MOOD 29
839 FOOD ALLERGY 29
840 GINGIVITIS 29
841 HAIR DISORDER 29
842 INFLAMMATORY MARKER INCREASED 29
843 LUNG INFECTION 29
844 NEPHROPATHY 29
845 NODULE 29
846 PERICARDIAL EFFUSION 29
847 PERONEAL NERVE PALSY 29
848 PHARYNGEAL SWELLING 29
849 PORPHYRIA ACUTE 29
850 SENSITIVITY TO WEATHER CHANGE 29
851 SMALL INTESTINAL OBSTRUCTION 29
852 SPINAL OPERATION 29
853 SPLENOMEGALY 29
854 SPUTUM DISCOLOURED 29
855 ATRIAL SEPTAL DEFECT 28
856 BLOOD LACTATE DEHYDROGENASE INCREASED 28
857 CONCUSSION 28
858 DELUSION 28
859 DEVICE DIFFICULT TO USE 28
860 HYPERKALAEMIA 28
861 MAJOR DEPRESSION 28
862 MALNUTRITION 28
863 MATERNAL EXPOSURE TIMING UNSPECIFIED 28
864 NEPHROGENIC ANAEMIA 28
865 NOCTURIA 28
866 PIGMENTATION DISORDER 28
867 PNEUMOTHORAX 28
868 SPINAL DISORDER 28
869 SQUAMOUS CELL CARCINOMA 28
870 SUNBURN 28
871 VAGINAL DISCHARGE 28
872 VENTRICULAR EXTRASYSTOLES 28
873 ADVERSE REACTION 27
874 BLINDNESS TRANSIENT 27
875 BLOOD MAGNESIUM DECREASED 27
876 BONE LOSS 27
877 CARDIAC FLUTTER 27
878 CHOKING SENSATION 27
879 DRUG EXPOSURE DURING PREGNANCY 27
880 FISTULA 27
881 GRIP STRENGTH 27
882 HYPERAESTHESIA 27
883 INJECTION SITE INFLAMMATION 27
884 INTERNATIONAL NORMALISED RATIO INCREASED 27
885 ISCHAEMIC STROKE 27
886 LIVE BIRTH 27
887 MACULAR DEGENERATION 27
888 MUCOSAL INFLAMMATION 27
889 PRODUCT ADHESION ISSUE 27
890 PRODUCT SHAPE ISSUE 27
891 SCOLIOSIS 27
892 SNORING 27
893 UNRESPONSIVE TO STIMULI 27
894 ANAL INCONTINENCE 26
895 ATAXIA 26
896 CARTILAGE INJURY 26
897 CHOLESTASIS 26
898 DEVICE BREAKAGE 26
899 DYSGRAPHIA 26
900 ENCEPHALOPATHY 26
901 EYELID PTOSIS 26
902 GENERAL SYMPTOM 26
903 HEARING IMPAIRED 26
904 JAW DISORDER 26
905 MANIA 26
906 MENISCUS INJURY 26
907 MYDRIASIS 26
908 OESOPHAGEAL DISORDER 26
909 OPTIC NEURITIS 26
910 PRODUCT PRESCRIBING ERROR 26
911 THERAPY CHANGE 26
912 ACUTE RESPIRATORY DISTRESS SYNDROME 25
913 APPLICATION SITE PRURITUS 25
914 COAGULOPATHY 25
915 COLON CANCER 25
916 DRUG TOLERANCE DECREASED 25
917 GENERALISED OEDEMA 25
918 GROIN PAIN 25
919 HEART RATE ABNORMAL 25
920 HEPATOTOXICITY 25
921 INJECTION SITE DISCOMFORT 25
922 KNEE OPERATION 25
923 LOWER GASTROINTESTINAL HAEMORRHAGE 25
924 LUNG INFILTRATION 25
925 MENOPAUSAL SYMPTOMS 25
926 MENSTRUAL DISORDER 25
927 MOUTH HAEMORRHAGE 25
928 PARKINSON^S DISEASE 25
929 POOR VENOUS ACCESS 25
930 PREMATURE BABY 25
931 PROCTALGIA 25
932 PRODUCT ADMINISTRATION INTERRUPTED 25
933 SKIN INFECTION 25
934 SKIN WARM 25
935 SPONDYLITIS 25
936 STREPTOCOCCAL INFECTION 25
937 SUSPECTED COUNTERFEIT PRODUCT 25
938 TENDON PAIN 25
939 THERAPEUTIC RESPONSE CHANGED 25
940 TOXIC SKIN ERUPTION 25
941 TRANSAMINASES INCREASED 25
942 URINE ODOUR ABNORMAL 25
943 WRONG PRODUCT ADMINISTERED 25
944 CYTOLYTIC HEPATITIS 24
945 EYE INFLAMMATION 24
946 GENERALISED ERYTHEMA 24
947 HEPATIC PAIN 24
948 INFUSION SITE PRURITUS 24
949 INFUSION SITE SWELLING 24
950 MELANOCYTIC NAEVUS 24
951 MUSCLE FATIGUE 24
952 NEUTROPHIL COUNT INCREASED 24
953 PLANTAR FASCIITIS 24
954 PRODUCT USED FOR UNKNOWN INDICATION 24
955 RESPIRATORY RATE INCREASED 24
956 SCRATCH 24
957 SPINAL COMPRESSION FRACTURE 24
958 ANGINA UNSTABLE 23
959 ARTERIAL OCCLUSIVE DISEASE 23
960 BLOOD POTASSIUM INCREASED 23
961 BONE LESION 23
962 CHAPPED LIPS 23
963 DRUG LEVEL INCREASED 23
964 FOOD POISONING 23
965 FULL BLOOD COUNT ABNORMAL 23
966 GASTRITIS EROSIVE 23
967 GASTROINTESTINAL INFECTION 23
968 HEPATIC FUNCTION ABNORMAL 23
969 HYDROCEPHALUS 23
970 INJECTION SITE DISCOLOURATION 23
971 LOW DENSITY LIPOPROTEIN INCREASED 23
972 OBSESSIVE-COMPULSIVE DISORDER 23
973 PERIORBITAL SWELLING 23
974 RESPIRATION ABNORMAL 23
975 SOMNAMBULISM 23
976 TRISMUS 23
977 AMENORRHOEA 22
978 AORTIC VALVE INCOMPETENCE 22
979 APPENDICITIS 22
980 APPLICATION SITE ERYTHEMA 22
981 ARTERIOSCLEROSIS 22
982 BLEPHAROSPASM 22
983 BLOOD ALBUMIN DECREASED 22
984 CARDIOMYOPATHY 22
985 CYANOSIS 22
986 DEPENDENCE 22
987 DERMATITIS ALLERGIC 22
988 EMPHYSEMA 22
989 EXPOSURE VIA SKIN CONTACT 22
990 GASTROINTESTINAL MOTILITY DISORDER 22
991 HEPATIC LESION 22
992 HEPATOMEGALY 22
993 HEREDITARY ANGIOEDEMA 22
994 INTERVERTEBRAL DISC DISORDER 22
995 MATERNAL EXPOSURE BEFORE PREGNANCY 22
996 METASTASES TO LIVER 22
997 ONYCHOMYCOSIS 22
998 POST PROCEDURAL HAEMORRHAGE 22
999 PRODUCT CONTAINER ISSUE 22